Interleukin-7 activates intestinal lymphocytes

Dig Dis Sci. 1995 Aug;40(8):1744-9. doi: 10.1007/BF02212696.

Abstract

Human intestinal lymphocytes, particularly intraepithelial lymphocytes, proliferate minimally to some agents, like mitogens and stimuli of the CD3 pathway. This in vitro finding may be due, in part, to a loss of factors found in vivo. Three T-cell growth factors, IL-7, IL-9, and IL-12, were tested for their ability to stimulate the proliferation of intestinal lymphocytes. Both intraepithelial lymphocytes and lamina propria lymphocytes proliferated more vigorously to IL-7 than to IL-9 or IL-12, and only IL-7 increased stimulation through the CD3 pathway. The IL-7-induced response was IL-2-dependent: IL-2 receptors appeared on both intestinal lymphocyte types, and antibody to the IL-2 receptor blocked IL-7-induced proliferation. Both CD4+ and CD8+ T-cell subsets responded to this cytokine as shown by phenotype-depletion experiments and constancy in the CD4/CD8 ratios after culture with IL-7. In addition, the T-cell receptor alpha beta and gamma delta subsets responded equally well to IL-7. This newly described selective proliferative response of intestinal lymphocytes to IL-7, but not to IL-9 or IL-12, requires no preactivation and may enhance growth in vivo.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies / pharmacology
  • CD3 Complex / immunology
  • CD4-CD8 Ratio
  • Epithelial Cells
  • Epithelium / immunology
  • Flow Cytometry
  • Humans
  • Interleukin-12 / pharmacology
  • Interleukin-2 / pharmacology
  • Interleukin-7 / pharmacology*
  • Interleukin-9 / pharmacology
  • Intestines / cytology*
  • Intestines / immunology
  • Lymphocyte Activation*
  • Receptors, Interleukin-2 / immunology

Substances

  • Antibodies
  • CD3 Complex
  • Interleukin-2
  • Interleukin-7
  • Interleukin-9
  • Receptors, Interleukin-2
  • Interleukin-12